Epiminder (ASX:EPI) Cash per Share: A$412.42 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:EPI Epiminder Ltd ASX:EPI
8 GF Score
Price A$0.46
View Full Analysis

What is Epiminder Cash per Share?

Epiminder ASX:EPI +4.55% 8 Cash per Share is A$412.42 as of Dec. 2025. GuruFocus rates ASX:EPI with a GF Score™ of 8/100.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Epiminder's Cash per Share for the quarter that ended in Dec. 2025 was A$412.42.

Epiminder  (ASX:EPI) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Epiminder Cash per Share Related Terms

Epiminder Cash per Share Historical Data

* Premium members only.

The historical data trend for Epiminder's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epiminder Cash per Share Chart

Epiminder Annual Data
Trend Jun23 Jun24 Jun25
Cash per Share
0.00 0.00 0.67

Epiminder Semi-Annual Data
Jun23 Jun24 Jun25 Dec25
Cash per Share 0.00 0.00 0.67 412.42
ASX:EPI
8GF Score
Epiminder Ltd ASX:EPI
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epiminder Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Epiminder's Cash per Share for the fiscal year that ended in Jun. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=116.952/175.19
=0.67

Epiminder's Cash per Share for the quarter that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=89.496/0.22
=412.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of A$412.42 mean?
Epiminder (ASX:EPI) has a Cash per Share of A$412.42 as of Dec. 2025. Cash per share is the per-share value of a company's available cash. View historical data for Epiminder and its competitors.
Is Epiminder's Cash per Share too high?
Epiminder's current Cash per Share is A$412.42. Overall, Epiminder has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Epiminder's Cash per Share compare to ABT and SYK?
Epiminder's Cash per Share of A$412.42 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Devices & Instruments company?
A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Epiminder and its competitors. Epiminder's current Cash per Share is A$412.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epiminder stock overvalued right now?
Epiminder (ASX:EPI) has a current Cash per Share of A$412.42. The current Cash per Share is A$412.42. Epiminder's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Epiminder (ASX:EPI), the current Cash per Share is A$412.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epiminder Business Description

Address 525 Collins Street, 210 West Podium, Mezzanine 2, Melbourne, VIC, AUS, 3000
Epiminder Ltd is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Its system is a sub-scalp device for continuous monitoring of electrographic brain activity and a set of information solutions, providing patients and their healthcare professionals with detailed data over an extended period.
8GF Score

Get the complete analysis for ASX:EPI

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.46
Price